BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32404338)

  • 1. Revisiting Filtration Fraction as an Index of the Risk of Hemofilter Clotting in Continuous Venovenous Hemofiltration.
    Hatamizadeh P; Tolwani A; Palevsky P
    Clin J Am Soc Nephrol; 2020 Nov; 15(11):1660-1662. PubMed ID: 32404338
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration.
    Kozek-Langenecker SA; Kettner SC; Oismueller C; Gonano C; Speiser W; Zimpfer M
    Crit Care Med; 1998 Jul; 26(7):1208-12. PubMed ID: 9671370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of low molecular weight dextran to prevent clotting during continuous renal replacement therapy.
    Palevsky PM; Burr R; Moreland L; Tokiwa Y; Greenberg A
    ASAIO J; 1995; 41(4):847-9. PubMed ID: 8589465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012467. PubMed ID: 33314078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circuit Survival during Continuous Venovenous Hemodialysis versus Continuous Venovenous Hemofiltration.
    Califano AM; Bitker L; Baldwin I; Fealy N; Bellomo R
    Blood Purif; 2020; 49(3):281-288. PubMed ID: 32088713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto Y; Miki S; Shimada H; Tsujimoto H; Yasuda H; Kataoka Y; Fujii T
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013330. PubMed ID: 34519356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous Renal Replacement Therapy in Venovenous Extracorporeal Membrane Oxygenation: A Retrospective Study on Regional Citrate Anticoagulation.
    Giani M; Scaravilli V; Stefanini F; Valsecchi G; Rona R; Grasselli G; Bellani G; Pesenti AM; Foti G
    ASAIO J; 2020 Mar; 66(3):332-338. PubMed ID: 31045918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous Renal Replacement Therapy Without Anticoagulation: Top Ten Tips to Prevent Clotting.
    Baldwin I; Jones D; Carty P; Fealy N
    Blood Purif; 2020; 49(4):490-495. PubMed ID: 31913144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012467. PubMed ID: 32164041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With Acute Respiratory Distress Syndrome and Acute Kidney Injury: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study.
    Allardet-Servent J; Castanier M; Signouret T; Soundaravelou R; Lepidi A; Seghboyan JM
    Crit Care Med; 2015 Dec; 43(12):2570-81. PubMed ID: 26488219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.
    de Pont AC; Bouman CS; Bakhtiari K; Schaap MC; Nieuwland R; Sturk A; Hutten BA; de Jonge E; Vroom MB; Meijers JC; Büller HR
    ASAIO J; 2006; 52(4):416-22. PubMed ID: 16883122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does continuous venovenous hemofiltration theoretically expose (ex-vivo models) inpatients to diethylhexyladipate, a plasticizer of PVC medical devices?
    Bernard L; Bailleau M; Eljezi T; Chennell P; Souweine B; Lautrette A; Sautou V
    Chemosphere; 2020 Jul; 250():126241. PubMed ID: 32105858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of regional citrate anticoagulation continuous venovenous hemofiltration in extracorporeal membrane oxygenation.
    Shum HP; Kwan AM; Chan KC; Yan WW
    ASAIO J; 2014; 60(4):413-8. PubMed ID: 24727536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible strategies to prolong circuit life during hemofiltration: three controlled studies.
    Baldwin I; Tan HK; Bridge N; Bellomo R
    Ren Fail; 2002 Nov; 24(6):839-48. PubMed ID: 12472205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.
    Ricci Z; Morelli S; Favia I; Garisto C; Brancaccio G; Picardo S
    Pediatr Crit Care Med; 2012 Jan; 13(1):e51-4. PubMed ID: 21057360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling acid-base balance for in-series extracorporeal carbon dioxide removal and continuous venovenous hemofiltration devices.
    Leypoldt JK; Kurz J; Echeverri J; Storr M; Harenski K
    Artif Organs; 2021 Sep; 45(9):1036-1049. PubMed ID: 33909323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous renal replacement therapy. Keeping the circuit open: lessons from the lab.
    Shulman RI; Singer M; Rock J
    Blood Purif; 2002; 20(3):275-81. PubMed ID: 11867875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building and validation of a prognostic model for predicting extracorporeal circuit clotting in patients with continuous renal replacement therapy.
    Fu X; Liang X; Song L; Huang H; Wang J; Chen Y; Zhang L; Quan Z; Shi W
    Int Urol Nephrol; 2014 Apr; 46(4):801-7. PubMed ID: 24638211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics Removal by Continuous Venovenous Hemofiltration with a Novel Asymmetric Triacetate Membrane Hemofilter: An in vitro Study.
    Körtge A; Majcher-Peszynska J; Heskamp B; Wasserkort R; Mitzner S
    Blood Purif; 2021; 50(6):899-905. PubMed ID: 33631754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit.
    Davenport A
    Am J Kidney Dis; 1997 Nov; 30(5 Suppl 4):S20-7. PubMed ID: 9372975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.